Kampanjeplan Ionis Pharmaceuticals
Avansert tidsplan
Enkel graf
Om selskapet Ionis Pharmaceuticals
Ionis Pharmaceuticals - биотехнологическая компания, базирующаяся в Карлсбаде, Калифорния, которая специализируется на открытии и разработке терапевтических средств, нацеленных на РНК. У компании есть 3 коммерчески одобренных препарата: Спинраза (Нусинерсен), Тегседи (Инотерсен) и WAYLIVRA, а также 4 препарата в основных исследованиях: томинерсен от болезни Хантингтона, тоферсен от SOD1-ALS, AKCEA-APO (a) -LRx от сердечно-сосудистых заболеваний. и AKCEA-TTR-LRx для всех форм амилоидоза TTR. До декабря 2015 года компания носила название Isis Pharmaceuticals. flere detaljerIPO date | 1991-05-17 |
---|---|
ISIN | US4622221004 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 3.16 |
Дивиденд ао | 0.66 |
Сайт | http://www.ionispharma.com |
Цена ао | 33.41 |
Prisendring per dag: | 0% (33.41) |
---|---|
Prisendring per uke: | -2.85% (34.39) |
Prisendring per måned: | +5.79% (31.58) |
Prisendring over 3 måneder: | -9.73% (37.01) |
Prisendring over seks måneder: | -20.81% (42.19) |
Prisendring per år: | -20.79% (42.18) |
Prisendring over 3 år: | -19.08% (41.29) |
Prisendring over 5 år: | -31.79% (48.98) |
Prisendring over 10 år: | -23.86% (43.88) |
Prisendring siden begynnelsen av året: | -8.54% (36.53) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Transaksjonsdato | Avsløringsdato | Insider | Type | Pris | Volum | Mengde | Del opp til, % | Del etterpå, % | Dokument |
---|---|---|---|---|---|---|---|---|---|
04.02.2025 | 06.02.2025 | Monia Brett P Chief Executive Officer |
Salg | 31.65 | 1 229 380 | 38843 | 0 | -0.03 | link |
04.02.2025 | 06.02.2025 | O'NEIL PATRICK R. EVP CLO & General Counsel |
Salg | 31.62 | 194 937 | 6165 | 0 | 0 | link |
16.01.2025 | 17.01.2025 | Baroldi Joseph EVP, Chief Business Officer |
Salg | 32.7 | 33 648 | 1029 | 0 | 0 | link |
16.01.2025 | 17.01.2025 | Baroldi Joseph EVP, Chief Business Officer |
Salg | 32.7 | 111 213 | 3401 | 0 | 0 | link |
16.01.2025 | 17.01.2025 | BENNETT C FRANK EVP, Chief Scientific Officer |
Salg | 32.9 | 222 141 | 6752 | 0 | 0 | link |
16.01.2025 | 16.01.2025 | Baroldi Joseph Officer |
Kjøpe | 32.7 | 111 213 | 3401 | 0 | 0 | link |
16.01.2025 | 16.01.2025 | BENNETT C FRANK Officer |
Kjøpe | 32.7 | 220 790 | 6752 | 0 | 0 | link |
16.01.2025 | 16.01.2025 | Birchler Brian Officer |
Kjøpe | 32.7 | 176 580 | 5400 | 0 | 0 | link |
16.01.2025 | 16.01.2025 | Devers Shannon L. Officer |
Kjøpe | 32.7 | 139 531 | 4267 | 0 | 0 | link |
16.01.2025 | 16.01.2025 | Geary Richard S Officer |
Kjøpe | 32.7 | 231 254 | 7072 | 0 | 0 | link |
16.01.2025 | 16.01.2025 | HOUGEN ELIZABETH L Officer |
Kjøpe | 32.7 | 290 049 | 8870 | 0 | 0.01 | link |
16.01.2025 | 16.01.2025 | Monia Brett P Officer |
Kjøpe | 32.7 | 1 093 650 | 33445 | 0 | 0.02 | link |
16.01.2025 | 16.01.2025 | O'NEIL PATRICK R. Officer |
Kjøpe | 32.7 | 240 672 | 7360 | 0 | 0.01 | link |
15.01.2025 | 17.01.2025 | Baroldi Joseph EVP, Chief Business Officer |
Kjøpe | 31.43 | 77 318 | 2460 | 0 | 0 | link |
15.01.2025 | 17.01.2025 | Baroldi Joseph EVP, Chief Business Officer |
Kjøpe | 31.43 | 276 175 | 8787 | 0 | 0.01 | link |
29.08.2024 | 03.09.2024 | Geary Richard S EVP, Chief Development Officer |
Salg | 49.63 | 16 428 | 331 | 0 | 0 | link |
28.08.2024 | 03.09.2024 | Geary Richard S EVP, Chief Development Officer |
Salg | 49.16 | 15 731 | 320 | 0 | 0 | link |
05.08.2024 | 05.08.2024 | Geary Richard S Executive Vice President, Chie |
Kjøpe | 49.13 | 153 679 | 3128 | 0 | 0 | link |
17.01.2024 | 18.01.2024 | O'NEIL PATRICK R. EVP CLO & General Counsel |
Salg | 50.42 | 390 452 | 7744 | 0 | -0.01 | link |
17.01.2024 | 18.01.2024 | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc |
Salg | 50.42 | 280 537 | 5564 | 0 | 0 | link |
16.01.2024 | 18.01.2024 | O'NEIL PATRICK R. EVP CLO & General Counsel |
Kjøpe | 50.65 | 1 045 470 | 20641 | 0 | 0.01 | link |
16.01.2024 | 18.01.2024 | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc |
Kjøpe | 50.65 | 762 890 | 15062 | 0 | 0.01 | link |
12.01.2024 | 17.01.2024 | Schneider Eugene EVP, Chf Clinical Develop Ofcr |
Salg | 53.5 | 428 000 | 8000 | 0 | -0.01 | link |
12.01.2024 | 17.01.2024 | Schneider Eugene EVP, Chf Clinical Develop Ofcr |
Kjøpe | 32.6 | 260 800 | 8000 | 0 | 0.01 | link |
07.07.2023 | 11.07.2023 | Monia Brett P Chief Executive Officer |
Salg | 42.25 | 787 963 | 18650 | 0 | -0.01 | link |
17.10.2022 | 18.10.2022 | Schneider Eugene EVP, Chf Clinical Develop Ofcr |
Kjøpe | 46.2 | 19 219 | 416 | 0 | 0 | link |
17.10.2022 | 18.10.2022 | Hayden Michael R Director |
Kjøpe | 46.2 | 82 097 | 1777 | 0 | 0 | link |
08.09.2022 | 12.09.2022 | Swayze Eric EVP Research |
Salg | 44.55 | 20 493 | 460 | 0 | 0 | link |
15.07.2022 | 19.07.2022 | BERTHELSEN SPENCER R Director |
Kjøpe | 39.28 | 314 161 | 7998 | 0 | 0.01 | link |
15.07.2022 | 19.07.2022 | Diaz Allene M. Director |
Kjøpe | 39.28 | 314 240 | 8000 | 0 | 0.01 | link |
15.07.2022 | 19.07.2022 | Hayden Michael R Director |
Kjøpe | 39.28 | 279 281 | 7110 | 0 | 0.01 | link |
15.07.2022 | 19.07.2022 | HERMAN JOAN E Director |
Kjøpe | 39.28 | 279 281 | 7110 | 0 | 0.01 | link |
15.07.2022 | 19.07.2022 | KLEIN JOSEPH III Director |
Salg | 38.24 | 50 974 | 1333 | 0 | 0 | link |
15.07.2022 | 19.07.2022 | KLEIN JOSEPH III Director |
Kjøpe | 39.28 | 314 161 | 7998 | 0 | 0.01 | link |
15.07.2022 | 19.07.2022 | LOSCALZO JOSEPH Director |
Kjøpe | 39.28 | 314 161 | 7998 | 0 | 0.01 | link |
15.07.2022 | 19.07.2022 | MUTO FREDERICK T Director |
Kjøpe | 39.28 | 314 161 | 7998 | 0 | 0.01 | link |
15.07.2022 | 19.07.2022 | PARSHALL B LYNNE Director |
Kjøpe | 39.28 | 314 161 | 7998 | 0 | 0.01 | link |
15.07.2022 | 19.07.2022 | WENDER JOSEPH H Director |
Kjøpe | 39.28 | 314 161 | 7998 | 0 | 0.01 | link |
02.12.2020 | 04.12.2020 | Monia Brett P Chief Executive Officer |
Salg | 51.32 | 1 085 930 | 21160 | 0 | -0.02 | link |
02.12.2020 | 04.12.2020 | Monia Brett P Chief Executive Officer |
Kjøpe | 39.87 | 843 649 | 21160 | 0 | 0.02 | link |
02.12.2020 | 04.12.2020 | BENNETT C FRANK Chief Scientific Officer |
Salg | 51.32 | 361 960 | 7053 | 0 | -0.01 | link |
02.12.2020 | 04.12.2020 | BENNETT C FRANK Chief Scientific Officer |
Kjøpe | 39.87 | 281 203 | 7053 | 0 | 0.01 | link |
25.11.2020 | 30.11.2020 | PARSHALL B LYNNE Director |
Salg | 50.05 | 179 680 | 3590 | 0 | 0 | link |
25.11.2020 | 30.11.2020 | PARSHALL B LYNNE Director |
Kjøpe | 39.87 | 143 133 | 3590 | 0 | 0 | link |
25.11.2020 | 30.11.2020 | Geary Richard S EVP, Development |
Salg | 50.05 | 596 596 | 11920 | 0 | -0.01 | link |
25.11.2020 | 30.11.2020 | Geary Richard S EVP, Development |
Kjøpe | 39.87 | 475 250 | 11920 | 0 | 0.01 | link |
25.11.2020 | 30.11.2020 | CROOKE STANLEY T Exec Chairman of the Board |
Salg | 50.05 | 650 150 | 12990 | 0 | -0.01 | link |
25.11.2020 | 30.11.2020 | CROOKE STANLEY T Exec Chairman of the Board |
Kjøpe | 39.87 | 517 911 | 12990 | 0 | 0.01 | link |
25.11.2020 | 30.11.2020 | HOUGEN ELIZABETH L EVP, Finance & CFO |
Salg | 50.05 | 1 085 080 | 21680 | 0 | -0.02 | link |
25.11.2020 | 30.11.2020 | HOUGEN ELIZABETH L EVP, Finance & CFO |
Kjøpe | 39.87 | 864 382 | 21680 | 0 | 0.02 | link |
Institusjoner | Volum | Dele, % |
---|---|---|
FMR, LLC | 21520872 | 14.77 |
Vanguard Group Inc | 14203481 | 9.74 |
T. Rowe Price Investment Management, Inc. | 13201453 | 9.06 |
Blackrock Inc. | 9057530 | 6.21 |
Bellevue Group AG | 8713987 | 5.98 |
ClearBridge Investments, LLC | 4707480 | 3.23 |
Wellington Management Group, LLP | 4616978 | 3.17 |
Price (T.Rowe) Associates Inc | 4255074 | 2.92 |
State Street Corporation | 4008797 | 2.75 |
Pictet Asset Management Holding SA | 3518317 | 2.41 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. Darren Gonzales | Chief Accounting Officer & Senior VP | N/A | |
Dr. Brett P. Monia Ph.D. | Founder, CEO & Director | 1.71M | 1961 (64 år) |
Ms. B. Lynne Parshall Esq., J.D. | Director | 334.64k | 1954 (71 år) |
Dr. C. Frank Bennett BSc, Ph.D. | Executive VP & Chief Scientific Officer | 651.64k | 1957 (68 år) |
Mr. D. Wade Walke Ph.D. | Senior Vice President of Investor Relations | N/A | |
Ms. Elizabeth L. Hougen M.A., M.B.A., M.S. | Executive VP of Finance & CFO | 1.02M | 1962 (63 år) |
Dr. Richard S. Geary Ph.D. | Executive VP & Chief Development Officer | 946.26k | 1958 (67 år) |
Ms. Hayley Soffer | Vice President of Corporate Communications | N/A | |
Dr. Eric E. Swayze Ph.D. | Executive Vice President of Research | 1966 (59 år) | |
Mr. Patrick R. O'Neil Esq. | Executive VP, Chief Legal Officer, General Counsel & Corporate Secretary | 1974 (51 år) |
Adresse: United States, Carlsbad, CA , 2855 Gazelle Court - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.ionispharma.com
Nettsted: http://www.ionispharma.com